Biologics Research Review, Issue 83 – Rheumatology focus
In this issue:
Adverse events with JAK inhibitors and biologic DMARDs
Telitacicept for active systemic lupus erythematosus
Anterior uveitis in axial SpA treated with biologics or targeted synthetics
S100A4 monoclonal antibody for systemic sclerosis
Tocilizumab and abatacept spacing in RA in remission
Sex differences in effectiveness of first-line TNF inhibitors in PsA
Withdrawal of sarilumab for glucocorticoid-dependent sarcoidosis
Frailty and risk of serious infections in RA
Switch from upadacitinib to adalimumab in RA
Oral glucocorticoids in RA patients initiating TNF inhibitors, tocilizumab or abatacept
Expert contributor
Professor Paul Bird
Paul Bird is a rheumatologist in private practice and Conjoint Professor at the University of New South Wales. In addition to his clinical duties, he is the Director of Optimus Clinical Research, a clinical research center undertaking phase 2, 3 and 4 trials of novel agents for the treatment of rheumatic diseases. He has completed […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.